Growing Trend of Novel or Experimental Substances Not Approved for Human Use Sold as Consumer Products Poses Threat to Athletes, Service Members, and Public Health
Drug Testing and Analysis, EarlyView.
Exposure to Drugs of Abuse in Children and Adolescents Investigated by Hair Analysis
Results of hair analysis of children and adolescents confirm that the evaluation of drug exposure through hair analysis needs special…
Umary and Related Products
Information regarding Umary, a product marketed as a dietary supplement
Human Drug Compounding
Compounded drugs can serve an important medical need for certain patients, they also present a risk to patients.
FDA Rationale for Recognition Decision: Amoxicillin and Clavulanate against Haemophilus influenzae
FDA Rationale for Recognition Decision: Amoxicillin and Clavulanate against Haemophilus influenzae
FDA approves retifanlimab-dlwr with carboplatin and paclitaxel and as a single agent for squamous cell carcinoma of the anal canal
FDA approves retifanlimab-dlwr with carboplatin and paclitaxel and as a single agent for squamous cell carcinoma of the anal canal
Online Controlled Substances Summits
FDA hosted its fourth summit on June 8, 2023, as an integral part of FDA’s overall efforts to protect the…
Nana Barseghian, M.D. – 708009 – 04/28/2025
Clinical Investigator
Umovy may be harmful due to hidden drug ingredients
The Food and Drug Administration is advising consumers not to purchase or use Umovy, a product promoted and sold for…
Unavy may be harmful due to hidden drug ingredients
The Food and Drug Administration is advising consumers not to purchase or use Unavy, a product promoted and sold for…